Acute spontaneous intracerebral haemorrhage is a life-threatening illness of global importance,
with a poor prognosis and few proven treatments. As a heterogeneous disease, certain …

Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …

Although improvements in thrombectomy devices, stroke management and patient selection
in clinical trials over the last two decades have occurred in concert with increasingly greater …

Background Among patients with a proximal vessel occlusion in the anterior circulation, 60
to 80% of patients die within 90 days after stroke onset or do not regain functional …

Background We aimed to assess the safety and efficacy of thrombectomy for the treatment
of stroke in a trial embedded within a population-based stroke reperfusion registry. Methods …

Background Thrombectomy is currently recommended for eligible patients with stroke who
are treated within 6 hours after the onset of symptoms. Methods We conducted a multicenter, …

Background Endovascular therapy is increasingly used after the administration of intravenous
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …

Background Transcranial Doppler ultrasonography that is aimed at residual obstructive
intracranial blood flow may help expose thrombi to tissue plasminogen activator (t-PA). Our …

Background: Thrombolytic therapy for acute stroke (<3 hours) will not have a major impact
on death and dependency unless it is accessible to more patients. Objective: To determine …

BACKGROUND AND PURPOSE: Clinicians are insecure reading CT scans by using the
one-third rule for acute middle cerebral artery stroke (1/3 MCA rule) before treating patients with …